The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks

By The Online Investor Staff, updated Sat., Dec. 20, 10:58 PM

#15 of the Dow 30: Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson is a holding company. Through its subsidiaries, Co. engages in three business segments. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, and nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The Pharmaceutical segment includes products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices and Diagnostics segment includes products used principally by physicians, nurses, hospitals, and clinics.
Open the JNJ Page at The Online Investor »

Company Name:  Johnson & Johnson
Website:  www.jnj.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding JNJ:  109
Total Market Value Held by ETFs:  $13.39B
Total Market Capitalization:  $291.30B
% of Market Cap. Held by ETFs:  4.60%

Open the JNJ Page at The Online Investor (in a new window) »

December 20, 2014    10:58 PM Eastern

Buy (2.87 out of 4)
36th percentile
(ranked lower than approx. 64% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite
Quotes delayed 20 minutes



Buy (2.87 out of 4)
36th percentile
(ranked lower than approx. 64% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks - Slide 1 of 15 | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.